Suvi Tuohinen
-
- Chemotherapy-induced cardiotoxicity and mitigation 22
- Cardiovascular Function and Risk Factors 10
- Physiology top 5%
- Sarcoidosis and Beryllium Toxicity Research 3
-
- Pulmonary Hypertension Research and Treatments 4
-
- Cardiac Imaging and Diagnostics 14
-
- Breast Cancer Treatment Studies 3
-
- Ultrasound and Hyperthermia Applications 4
-
- Cancer Treatment and Pharmacology 3
- Co-authors
- Tanja SkyttäPekka RaatikainenPirkko‐Liisa Kellokumpu‐LehtinenVesa VirtanenHeikki MiettinenTapani VihinenPetri HaatajaMarkku Kupari
- Journals
- Anticancer Research (4 papers)Radiation Oncology (4 papers)European Heart Journal - Cardiovascular Imaging (3 papers)
- Partner nations
- FinlandNetherlandsDenmark
In The Last Decade
Suvi Tuohinen
30 papers receiving 761 citations
Hit Papers
Peers
Comparison fields: 5 of 50
- Cardiology and Cardiovascular Medicine 395
- Physiology 372
- Pulmonary and Respiratory Medicine 381
- Radiology, Nuclear Medicine and Imaging 245
- Cancer Research 64
Countries citing papers authored by Suvi Tuohinen
This map shows the geographic impact of Suvi Tuohinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suvi Tuohinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suvi Tuohinen more than expected).
Fields of papers citing papers by Suvi Tuohinen
This network shows the impact of papers produced by Suvi Tuohinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suvi Tuohinen. The network helps show where Suvi Tuohinen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Suvi Tuohinen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 7 | |
| 6 | 2022 | 0 | |
| 7 | 2022 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 13 | |
| 11 | 2019 | 8 | |
| 12 | 2019 | 13 | |
| 13 | 2019 | 18 | |
| 14 | 2019 | 22 | |
| 15 | 2018 | 10 | |
| 16 | 2017 | 2 | |
| 17 | 2016 | 42 | |
| 18 | 2015 | 107 | |
| 19 | 2015 | 37 | |
| 20 | 2014 | 12 |
About Suvi Tuohinen
Suvi Tuohinen is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Pulmonary and Respiratory Medicine, having authored 34 papers that have together received 773 indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (22 papers), Cardiac Imaging and Diagnostics (14 papers), Cardiovascular Function and Risk Factors (10 papers), Ultrasound and Hyperthermia Applications (4 papers), Pulmonary Hypertension Research and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers), Sarcoidosis and Beryllium Toxicity Research (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (395 citations), Physiology (372 citations) and Pulmonary and Respiratory Medicine (381 citations). Suvi Tuohinen has collaborated with scholars based in Finland, Netherlands and Denmark. Frequent co-authors include Tanja Skyttä, Pekka Raatikainen, Pirkko‐Liisa Kellokumpu‐Lehtinen, Vesa Virtanen, Heikki Miettinen, Tapani Vihinen, Petri Haataja, Markku Kupari, Riina Kandolin and Jukka Lehtonen. Their work appears in journals such as Anticancer Research, Radiation Oncology, European Heart Journal - Cardiovascular Imaging, International journal of cardiac imaging and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.